COVID-19: DCGI approves Serum Institute to manufacture Sputnik V vaccine in India
Published
SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V.
Full ArticlePublished
SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V.
Full Article(MENAFN - NewsBytes) For much of the past one-and half year, children have been unable to attend classes physically at their..
SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V..